This fact could be justified due to the absence of the action of VITD metabolites that increase the expression of lipoprotein lipase [25,26] in vitro [27], as well as the increased number of patients with peripheral insulin resistance in this group, which may cause a decrease in triglyceride levels. This evidence concerns the gene LPL and Insulin resistance.